"Avexa disclosed in its 30 June 2010 Annual Accounts that it held cash reserves of $24.3million, that Avexa's research and development activities are currently on hold and that staff numbers had been substantially reduced.
Avexa expects its operating loss before abnormal items and income tax for the half year ending 31 December 2010 to be at least 50% less than the loss for the previous corresponding period"
